Michael R. Kosorok

Michael R. Kosorok

Auto-generated profile, based on publicly available information

Michael R. Kosorok

Department of Biostatistics University of North Carolina at Chapel Hill, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
SMShuangge Ma
Shuangge Ma
MKMichael R Kosorok
Michael R Kosorok
Prognosis is of critical interest in breast cancer research. Biomedical studies suggest that genomic measurements may have independent predictive power for prognosis. Gene profiling studies have been conducted to search for predictive genomic measurements. Genes have the inherent pathway structure, where pathways are composed of multiple genes with coordinated functions. The goal of this study is to identify gene pathways with predictive power for breast cancer prognosis. Since our goal is fundamentally different from that of existing studies, a new pathway analysis method is proposed.

4 June 2012 in Journal of the American Statistical Association
Verified
Journal Article
Closed access
YZYingqi Zhao
Yingqi Zhao
DZDonglin Zeng
Donglin Zeng
ARA. John Rush
A. John Rush
MKMichael R. Kosorok
Michael R. Kosorok
There is increasing interest in discovering individualized treatment rules (ITRs) for patients who have heterogeneous responses to treatment. In particular, one aims to find an optimal ITR that is a deterministic function of patient-specific characteristics maximizing expected clinical outcome. In this article, we first show that estimating such an optimal treatment rule is equivalent to a classification problem where each subject is weighted proportional to his or her clinical outcome. We then propose an outcome weighted learning approach based on the support vector machine framework. We show that the resulting estimator of the treatment rule is consistent. We further obtain a finite sample bound for the difference between the expected outcome using the estimated ITR and that of the optimal treatment rule. The performance of the proposed approach is demonstrated via simulation studies and an analysis of chronic depression data.

1 March 2019 in Annual Review of Statistics and Its Application
Verified
Journal Article
Closed access
MKMichael R. Kosorok
Michael R. Kosorok
ELEric B. Laber
Eric B. Laber
Precision medicine seeks to maximize the quality of health care by individualizing the health-care process to the uniquely evolving health status of each patient. This endeavor spans a broad range of scientific areas including drug discovery, genetics/genomics, health communication, and causal inference, all in support of evidence-based, i.e., data-driven, decision making. Precision medicine is formalized as a treatment regime that comprises a sequence of decision rules, one per decision point, which map up-to-date patient information to a recommended action. The potential actions could be the selection of which drug to use, the selection of dose, the timing of administration, the recommendation of a specific diet or exercise, or other aspects of treatment or care. Statistics research in precision medicine is broadly focused on methodological development for estimation of and inference for treatment regimes that maximize some cumulative clinical outcome. In this review, we provide an overview of this vibrant area of research and present important and emerging challenges.

11 September 2009 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
YZYufan Zhao
Yufan Zhao
MKMichael R. Kosorok
Michael R. Kosorok
DZDonglin Zeng
Donglin Zeng

8 March 2011 in Biometrics
Verified
Journal Article
Closed access
PDF file
YZYufan Zhao
Yufan Zhao
DZDonglin Zeng
Donglin Zeng
MSMark A. Socinski
Mark A. Socinski
MKMichael R. Kosorok
Michael R. Kosorok

3 April 2015 in Journal of the American Statistical Association
Verified
Journal Article
Closed access
YZYing-Qi Zhao
Ying-Qi Zhao
DZDonglin Zeng
Donglin Zeng
ELEric B. Laber
Eric B. Laber
MKMichael R. Kosorok
Michael R. Kosorok
Dynamic treatment regimes (DTRs) are sequential decision rules for individual patients that can adapt over time to an evolving illness. The goal is to accommodate heterogeneity among patients and find the DTR which will produce the best long-term outcome if implemented. We introduce two new statistical learning methods for estimating the optimal DTR, termed backward outcome weighted learning (BOWL), and simultaneous outcome weighted learning (SOWL). These approaches convert individualized treatment selection into an either sequential or simultaneous classification problem, and can thus be applied by modifying existing machine learning techniques. The proposed methods are based on directly maximizing over all DTRs a nonparametric estimator of the expected long-term outcome; this is fundamentally different than regression-based methods, for example, Q-learning, which indirectly attempt such maximization and rely heavily on the correctness of postulated regression models. We prove that the resulting rules are consistent, and provide finite sample bounds for the errors using the estimated rules. Simulation results suggest the proposed methods produce superior DTRs compared with Q-learning especially in small samples. We illustrate the methods using data from a clinical trial for smoking cessation. Supplementary materials for this article are available online.